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Abstract
Background: The habenula plays an important role in regulating behavioral responses to stress and shows
increased cerebral blood flow and decreased gray matter volume in patients with mood disorders. Here, we
compare the volume of the habenula in unmedicated patients with post-traumatic stress disorder (PTSD) and
healthy controls (HC) using MRI.
Findings: High-resolution images (resolution of approximately 0.4 mm3) were acquired using a 3T scanner and a
pulse sequence optimized for tissue contrast resolution. The habenula was manually segmented by one rater blind
to diagnosis. PTSD and HC participants did not differ significantly in absolute or normalized habenula volume. Post
hoc analyses controlling for the effects of comorbid major depressive disorder (MDD) and type and age of trauma
exposure were not significant. Further, there was no association between PTSD severity and habenula volume.
Conclusions: Our data suggest that PTSD is not associated with robust structural changes in the habenula. The
modest size of the PTSD sample may have reduced statistical power thereby accounting for the negative results
obtained.
Introduction
Post-traumatic stress disorder (PTSD) is associated with
an impaired ability to extinguish conditioned fear
responses to threatening stimuli. This deficit attributed is
hypothesized to reflect deficient inhibition of the amyg-
dala by the ventromedial prefrontal cortex (vmPFC)
[1-3]. Nevertheless, additional neurocircuitry likely is
involved in the pathophysiology of PTSD. The habenula
receives projections from limbic regions, including the
vmPFC, and modulates cortical function via its projec-
tions to the raphe and ventral tegmental area (VTA) [4].
Conditioned aversive stimuli have been shown to activate
the habenula, inhibiting VTA-mediated dopamine release
and potentially both inhibiting and facilitating raphe-
mediated serotonin release [4]. Conceivably, therefore,
the habenula may a key role in the inhibition of condi-
tioned fear, and by extension, PTSD.
The extant preclinical data appear consistent with this
hypothesis. Rats exposed to chronic stress or undergoing
dopamine depletion showed elevated glucose metabo-
lism in the lateral habenula that was prevented by
administration of an antidepressant [5]. Similarly, rats
exposed to inescapable shock no longer developed
learned helplessness after lesioning of the habenula [6],
a finding that receives support from a more recent
study demonstrating that lesioning of the lateral habe-
nula results in increased serotonin turnover in the dor-
sal raphe concomitant with decreased immobility time
in the forced-swim test [7]. The potential relationship
between habenula function and stress is supported by
the finding that congenitally helpless rats show a 64% to
71% elevation in habenula metabolism compared with
non-helpless strains [8], which is reduced, together with
immobility in the forced swim test, by fluoxetine [9].
In humans, using arterial spin labeling and an emotional
word processing paradigm we have previously shown that
remitted major depressive disorder (MDD) patients had
greater blood flow to the habenula than healthy controls
after acute tryptophan depletion [10]. A recent postmor-
tem study reported a reduction in volume, neuronal num-
bers and neuronal cell area of the medial habenula in
patients with affective illness [11]. Consistent with these
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data, we recently reported a decrease in the habenula
volume of unmedicated patients with bipolar disorder
(BD) and female patients with MDD [12]. Elucidation of
the role of the habenula in stress and depression may have
future clinical applications; deep brain stimulation of the
lateral habenula was found to induce remission of symp-
toms in a patient with treatment refractory MDD [13].
Here, using high-resolution imaging, we conduct the
first MRI study of habenula volume in PTSD. Based on
the literature and our findings in patients with affective
illness, which indicate elevated activity of the habenula
during stress (possibly leading to excitotoxicity), we
hypothesized that patients with PTSD would show smal-
ler habenula volumes than healthy subjects.
Methods
Subjects gave written informed consent to participate, as
approved by the National Institutes of Mental Health
Institutional Review Board (NIMH IRB). Patients (n =
22) met Diagnostic and Statistical Manual of Mental Dis-
orders, fourth edition (DSM-IV) criteria for chronic
PTSD based upon the Structured Clinical Interview for
the DSM-IV (SCID-IV), and the Clinician-Administered
PTSD Scale (CAPS) [14]. All patients were medication
free for at least 3 weeks (6 weeks for fluoxetine) prior to
scanning. A total of 15 patients were medication naïve.
Seven patients were previously been treated with medica-
tion, six with antidepressants (mostly selective serotonin
reuptake inhibitors (SSRIs), three combined with a ben-
zodiazepine), and one with a benzodiazepine, alone. The
sample was evenly divided into currently depressed and
non-depressed patients. One patient had generalized
anxiety, and another had a specific phobia. No patients
had comorbid BD. Symptoms of depression and anxiety
were rated using the Inventory of Depressive Symptoma-
tology (IDS) [15] and Hamilton Rating Scale for Anxiety
(HAM-A) [16], respectively.
A total of 11 PTSD subjects experienced prolonged
prepubertal trauma: sexual (N = 6) or physical/emotional
(N = 5) abuse. A total of 11 PTSD subjects were exposed
to a single traumatic event in adulthood: sexual assault
(N = 4), motor vehicle accident (N = 4), and assault/rob-
bery (N = 3). The time elapsed from exposure to trauma
(mean ± SD) was 9.3 ± 8.0 years in the adult single
trauma group and 26.0 ± 4.0 years in patients who under-
went prolonged prepubertal trauma. The Early Trauma
Inventory (ETI) [17] was used to document childhood
trauma.
The following exclusion criteria applied: a CAPS score
of less than 50, significant medical disorders, past head
injury with loss of consciousness, significant risk of sui-
cide, meeting DSM-IV criteria for substance abuse or
dependence within the previous 6 months, general MRI
exclusion criteria or positive illicit drug or HIV screen.
Healthy control (HC) subjects (n = 75) met the same
exclusion criteria, had no current or lifetime history of a
psychiatric disorder or exposure to trauma, and no first
degree relative with a mood or anxiety disorder, as estab-
lished using the Family Interview for Genetic Studies
(FIGS) [18]. The HC data were used in a previous study
of habenula volume in mood disorders [12].
High-resolution anatomical images were acquired using
a GE, Waukesha, WI, USA 3T MRI scanner, a standard
head radiofrequency coil, and a magnetization-prepared,
rapid gradient echo (MP-RAGE) pulse sequence: (echo
time (TE) = 2.1 ms, repetition time (TR) = 7.8 ms, flip
angle = 6°). In all, 124 coronal slices (slice thickness = 0.6
mm) were acquired with a 14 cm field-of-view and in-
plane resolution of 224 × 224 voxels, resampled to 256 ×
256 × 124 voxels for reconstruction, resulting in a dis-
played resolution of 0.55 × 0.55 × 0.6 mm. Three to four
13-min scans were consecutively acquired, coregistered,
and summed to increase signal-to-noise ratio. Prior to
analysis the signal-to-noise ratio was increased by sum-
ming each of two consecutive coronal planes to enhance
the accuracy of manual segmentation. Thus the in-plane
voxel size remained at 0.55 × 0.55 mm while the coronal
slice thickness increased to 1.2 mm for segmentation
(three-dimensional volumetric resolution approximately
0.4 mm3).
A second MP-RAGE image of the entire brain also was
acquired to measure whole brain volume (WBV) (TE =
4.94 ms; TR = 11.6 ms, preparation time = 725 ms; delay
time = 1400 ms; voxel size = 0.85 × 0.85 × 1.2 mm).
The habenula was segmented by one rater (WB), blind
to diagnosis, in each coronal plane in which this structure
was seen bulging into the third ventricle along the ventro-
medial aspect of the thalamus or lying ventral and medial
to the stria medullaris of the thalamus. The medial bound-
ary was formed by the cerebrospinal fluid of the third ven-
tricle, and the ventral boundary by the white matter of the
posterior commissure. The dorsal and lateral borders were
defined by the white matter of the stria medullaris of the
thalamus in anterior planes or the mediodorsal thalamic
nucleus, limitans nucleus or pretectal area in posterior
planes (Figure 1). Using this method, we have previously
obtained an inter-rater reliability coefficient for segmenta-
tion of 0.97 for the left habenula and 0.95 for the right
habenula [12].
WBV was measured using the FSL tool, FAST [19].
The whole brain image was segmented into gray matter,
white matter and cerebrospinal fluid images, after cor-
recting for intensity non-uniformity using the MINC
tool, N3. The gray and white matter components then
were summed to generate the WBV.
Independent sample t tests (two-tailed, a = 0.05) were
used to compare the groups on clinical and demographic
variables. There was no significant difference between
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the control and PTSD groups in gender distribution or
age (Table 1). However, more PTSD subjects than con-
trols were left handed and therefore a general linear
model (two-tailed, a = 0.05) with handedness as a covari-
ate was used to test our a priori hypothesis that habenula







Figure 1 Coronal MRI sections showing the habenula and the local anatomical landmarks that enabled its segmentation. Because the
habenular nuclei contain relatively dense white matter plexuses they can be delimited from the gray matter of the adjacent thalamus
dorsolaterally, and by the limitans nucleus and pretectal area ventrolaterally [23]. Moreover, in posterior planes the habenula is clearly evident as
a pyramidal-shaped structure that bulges into the third ventricle along the ventromedial aspect of the thalamus, whereas in anterior planes it
can be delimited ventrally and medially from the thalamus by the stria medullaris of thalamus (the white matter track that delimits the
ventromedial aspect of the medial thalamus). In the image shown the habenular location shows sufficient asymmetry that the typical view of
the posterior aspect is illustrated by the habenular nuclear complex located on the reader’s left, while the latter case is illustrated by the
habenular complex on the reader’s right. Finally, the habenular nuclei are delimited ventrally by the white matter of the posterior commissure.
The medial and lateral habenular nuclei could not be resolved specifically, so were combined within a single habenular volume-of-interest. The
upper and lower panels are identical images. The tracing of the habenula is shown in yellow in the lower panel.
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Results
No significant volumetric difference was found between
groups (Table 1). The difference in habenula volume
between the groups remained non-significant when the
analysis was limited to females or right-handed indivi-
duals. Post hoc tests were also carried out to evaluate
whether PTSD patients with concurrent MDD differed
in total habenula volume from PTSD patients without
MDD or HC subjects. We also tested whether PTSD
patients with prepubertal trauma differed in total habe-
nula volume from PTSD patients with adult-onset
trauma or HC subjects, and whether the type of PTSD-
inducing trauma impacted habenula volumes. The mean
absolute and normalized volumes did not differ signifi-
cantly between groups (all P values > 0.3). Further, there
was no significant correlation between total habenula
volume and the CAPS, IDS, or HAM-A scores of the
PTSD group (CAPS: r = 0.103, P = 0.716; IDS: r = 0.22,
P = 0.318; HAM-A: r = 0.08, P = 0.745). CAPS subscale
scores also did not correlate significantly with habenula
volume in the PTSD group: CAPS-A (r = 0.042, P =
0.881), CAPS-B (r = 0.343, P = 0.211), and CAPS-C (r =
-0.205, P = 0.463). Similarly, there was no significant
association between total ETI score and total habenula
volume (r = -0.237, P = 0.415).
Discussion
Theoretically, the negative results reported here could
be due to the modest PTSD sample size. Neverthless,
we note that we found significant habenula volume
reductions in a sample of 22 patients with BD (Cohen’s
f2 = 0.12) and 15 female patients with MDD (f2 = 0.11)
[12]. (By convention, effect sizes of 0.02, 0.15, and 0.35
are termed small, medium, and large, respectively [20].)
Thus our study may have been adequately powered to
detect habenula volume changes of a moderate effect
size. Nevertheless, it is possible that habenula abnormal-
ities are only present in particular subtypes of PTSD
patients that would yield a small effect size across a het-
erogeneous patient sample. In this case our study may
not have been adequately powered to detect such a
structural effect.
Several limitations of our study design merit com-
ment. Even with high-resolution images, it remains diffi-
cult to accurately segment the habenula from adjacent
tissues. However, there is no reason to expect that the
extent of any errors would differ systematically between
PTSD patients and controls since segmentation was per-
formed blind to subject identity/diagnosis. Further, cur-
rent MRI technology does not allow the lateral and
medial habenula to be distinguished from each other.
Table 1 Clinical and volumetric data and statistical differences between the post-traumatic stress disorder (PTSD) and
healthy control groups
PTSD Healthy controls Comparison (statistic, df, P value)
N 22 75 -
Age 34.8 ± 10.4 36.9 ± 11.9 t = 0.7, 95, 0.472
Gender (% female) 77% 61% c2 = 1.9, 1, 0.168
Handedness (r/l) 18/4 72/3 c2 = 5.1, 1, 0.024*
Trauma exposure (childhood/adult) 9/13 NA -
Type of trauma (sexual abuse/physical abuse/other) 10/6/6 NA -
Concurrent MDD episode (yes/no) 11/11 NA -
History of substance abuse (yes/no) 2/20 NA -
IDS score 21.4 ± 14.1 0.7 ± 1.3 t = 8.9, 57, < 0.001**
CAPS score 76.4 ± 16.6 NA -
HAM-A score 10.3 ± 6.1 0.4 ± 0.8 t = 12.0, 75, < 0.001**
Total brain volume (mm3) 1 144 067 ± 94962 1 174 544 ± 118 902 F = 1.2, 1, 0.278
Left habenula volume (mm3) 18.8 ± 3.6 19.8 ± 5.1 F = 0.8, 1, 0.384
Normalized left habenula volume 0.000016 ± 0.0000036 0.000017 ± 0.0000052 F = 0.1, 1, 0.999
Right habenula volume (mm3) 16.4 ± 3.7 17.1 ± 4.6 F = 0.2, 1, 0.688
Normalized right habenula volume 0.000014 ± 0.0000032 0.000015 ± 0.0000044 F = 0.1, 1, 0.999
Total habenula volume (mm3) 35.2 ± 6.7 36.9 ± 8.5 F = 0.7, 1, 0.403
Normalized total habenula volume 0.000031 ± 0.0000062 0.000032 ± 0.0000094 F = 0.3, 1, 0.589
CAPS = Clinician-Administered PTSD Scale; IDS = Inventory of Depressive Symptomatology; HAM-A = Hamilton Anxiety Rating scale; MDD = major depressive
disorder; NA = not applicable.
* p < 0.05
** p < 0.01
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Thus, it is possible that PTSD patients would have dis-
played structural changes in either the medial or lateral
habenula were these regions measured separately.
In summary, although we found no significant differ-
ences between groups, given the habenula’s central role
in adaptation to stressful events [6,21,22], future, better-
powered studies are needed to definitively establish the
presence or absence of structural habenula effects in
PTSD. For example, based upon the mean group differ-
ence and variance in habenula volumes measured herein
(Cohen’s d = 0.2), a future study would have 80% power
to detect a difference in mean habenula volumes
between PTSD and HC samples using a one-tailed t test
with an approximate sample size of 300 cases and 300
controls.
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